X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11110) 11110
Book Review (2053) 2053
Publication (1366) 1366
Book Chapter (103) 103
Conference Proceeding (73) 73
Dissertation (33) 33
Archival Material (1) 1
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7653) 7653
humans (6934) 6934
braf (5787) 5787
oncology (4270) 4270
mutation (3937) 3937
cancer (3416) 3416
melanoma (3324) 3324
female (3318) 3318
male (3112) 3112
proto-oncogene proteins b-raf - genetics (3071) 3071
middle aged (2617) 2617
aged (2127) 2127
adult (2101) 2101
braf mutation (2064) 2064
tumors (1742) 1742
pathology (1668) 1668
genetic aspects (1515) 1515
braf mutations (1445) 1445
prognosis (1396) 1396
colorectal cancer (1331) 1331
metastasis (1288) 1288
melanoma - genetics (1242) 1242
gene mutations (1220) 1220
metastatic melanoma (1202) 1202
vemurafenib (1197) 1197
mutations (1191) 1191
carcinoma (1148) 1148
animals (1116) 1116
kras (1094) 1094
cell biology (1085) 1085
survival (1074) 1074
research (1069) 1069
melanoma - pathology (1065) 1065
analysis (1060) 1060
aged, 80 and over (1047) 1047
expression (1041) 1041
melanoma - drug therapy (1013) 1013
thyroid neoplasms - genetics (978) 978
cell line, tumor (967) 967
immunohistochemistry (963) 963
care and treatment (960) 960
neoplasms (956) 956
microsatellite instability (939) 939
thyroid cancer (939) 939
colorectal neoplasms - genetics (915) 915
article (903) 903
dermatology (859) 859
thyroid neoplasms - pathology (857) 857
dna mutational analysis (810) 810
proto-oncogene proteins b-raf - metabolism (763) 763
diagnosis (753) 753
kinases (752) 752
chemotherapy (747) 747
surgery (729) 729
activation (726) 726
antineoplastic agents - therapeutic use (720) 720
proto-oncogene proteins b-raf - antagonists & inhibitors (702) 702
braf v600e mutation (680) 680
endocrinology & metabolism (678) 678
skin neoplasms - pathology (677) 677
young adult (676) 676
health aspects (675) 675
colorectal neoplasms - pathology (670) 670
gene (666) 666
biomarkers, tumor - genetics (663) 663
pathway (643) 643
resistance (641) 641
medicine & public health (637) 637
skin neoplasms - genetics (635) 635
therapy (625) 625
mice (609) 609
malignant-melanoma (606) 606
ras proteins - genetics (604) 604
adolescent (603) 603
open-label (601) 601
b-raf (596) 596
digestive system diseases (593) 593
retrospective studies (590) 590
mutation - genetics (585) 585
immunotherapy (579) 579
biochemistry & molecular biology (573) 573
signal transduction (568) 568
colon-cancer (558) 558
treatment outcome (546) 546
patients (545) 545
targeted therapy (544) 544
gene expression (543) 543
proteins (542) 542
medicine, research & experimental (541) 541
abridged index medicus (540) 540
neoplasm staging (539) 539
development and progression (535) 535
acquired-resistance (526) 526
dna methylation (515) 515
inhibition (512) 512
genes (509) 509
papillary thyroid carcinoma (504) 504
melanoma - metabolism (502) 502
proto-oncogene proteins - genetics (501) 501
dabrafenib (497) 497
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10828) 10828
German (121) 121
French (117) 117
Spanish (57) 57
Korean (33) 33
Russian (22) 22
Czech (17) 17
Chinese (16) 16
Polish (15) 15
Japanese (10) 10
Portuguese (8) 8
Hungarian (7) 7
Turkish (4) 4
Dutch (3) 3
Italian (2) 2
Slovenian (2) 2
Croatian (1) 1
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 07/2017, Volume 28, Issue 7, pp. 1673 - 1675
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2014, Volume 14, Issue 1, pp. 13 - 13
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2011, Volume 128, Issue 9, pp. 2075 - 2084
BRAF V600E mutations are found in 10% of colorectal cancers (CRCs). The low frequency of this mutation therefore makes it a challenging target for drug... 
prognosis | BRAF | colorectal cancer | Prognosis | Colorectal cancer
Journal Article
Oncotarget, ISSN 1949-2553, 05/2016, Volume 7, Issue 21, pp. 30109 - 30118
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 03/2012, Volume 3
The development of acquired drug resistance hampers the long-term success of B-RAF inhibitor therapy for melanoma patients. Here we show B-V600E-RAF... 
MULTIDISCIPLINARY SCIENCES | BRAF | MUTATIONS | OVERCOME
Journal Article
Cancer Research, ISSN 0008-5472, 2019, Volume 79, Issue 6, pp. 1047 - 1053
Kinase fusions are rare and poorly characterized in colorectal carcinoma, yet they present unique opportunities for targeted therapy. In this study, we... 
ONCOLOGY | CANCER | BRAF
Journal Article
Pigment Cell & Melanoma Research, ISSN 1755-1471, 03/2016, Volume 29, Issue 2, pp. 222 - 228
BRAF mutations at codons L597 and K601 occur uncommonly in melanoma. Clinical and pathological associations of these mutations were investigated in a cohort of... 
mutation | BRAF | K601E | L597 | primary melanoma | BRAF L597 | Primary melanoma | BRAF K601E | BRAF mutation | Genetic aspects | Melanoma
Journal Article
Annals of Oncology, ISSN 0923-7534, 01/2019, Volume 30, Issue 1, pp. 155 - 156
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 09/2014, Volume 38, Issue 9, pp. 1235 - 1241
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 02/2019, Volume 180, Issue 2, pp. 421 - 422
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 50, Issue 3, pp. 611 - 621
Abstract Background & Aim Brain metastases are frequent in patients with metastatic melanoma, indicating poor prognosis. We investigated the BRAF kinase... 
Hematology, Oncology and Palliative Medicine | Vemurafenib | Symptomatic brain metastases | Tumour regression | BRAF inhibitor | Safety | Advanced melanoma | BRAF mutation
Journal Article
PEDIATRIC BLOOD & CANCER, ISSN 1545-5009, 07/2014, Volume 61, Issue 7, pp. 1173 - 1179
Background Clinical outcome of papillary thyroid carcinoma (PTC) in children differs significantly from that of adults. There is no clear explanation of this... 
SURVIVAL | MULTICENTER | CHILDHOOD | SPONTANEOUS REGRESSION | SOCIETY | BRAF mutation | BRAF V600E | pediatric BRAF mutation | PILOCYTIC ASTROCYTOMAS | ONCOLOGY | MALIGNANT-TRANSFORMATION | PEDIATRICS | MUTATIONS | pediatric thyroid carcinoma | HEMATOLOGY
Journal Article
JAMA SURGERY, ISSN 2168-6254, 12/2018, Volume 153, Issue 12, pp. 1162 - 1163
Journal Article
CANCER, ISSN 0008-543X, 04/2017, Volume 123, Issue 8, pp. 1372 - 1381
BACKGROUNDBRAF(V600), NRAS, TP53, and BRAF(Non-V600) are among the most common mutations detected in non-acral cutaneous melanoma patients. Although several... 
SURVIVAL | HEAD | BRAF(V600) | METASTASES | melanoma | BRAF | P53 MUTATIONS | IMPACT | mutations | ONCOLOGY | BRAF(Non-V600) | INHIBITOR | TP53
Journal Article
BLOOD, ISSN 0006-4971, 08/2015, Volume 126, Issue 8, pp. 1005 - 1008
Hairy cell leukemia (HCL) is marked by near 100% mutational frequency of BRAFV600E mutations. Recurrent cooperating genetic events that may contribute to HCL... 
BRAF INHIBITION | HEMATOLOGY | EXPRESSION | CANCER
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.